SPY
764.73
−0.60%
QQQ
704.30
−1.54%
BTC/USD
78,621.00
+1.06%
DIA
522.92
+0.04%
GLD
367.16
−0.38%
TLT
81.73
+0.29%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Chemed Corp
CHE
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$541.92
8.56
1.6%
Last update: Oct 29, 4:00 PM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Dividends
Compare
Options
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 Earnings were released on Tue Oct 27th, after the market close
Conference Call:
The most recent conference call started at 10:00 AM, 2 days ago
Click to view the webcast
Chemed Financials
Chemed (CHE) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Chemed FY2026 Adj EPS expected to be more than $25.75 vs $25.49 Est
Chemed (NYSE:CHE) FY2026 expected to be more than $25.75 vs $25.49 Est..
Benzinga Newsdesk
PRO
Chemed Q3 Adj. EPS $6.75 Beats $6.44 Estimate, Sales $690.940M Beat $685.037M Estimate
Benzinga Newsdesk
PRO
Chemed Q2 Adj. EPS $6.06 Beats $5.60 Estimate, Sales $673.251M Beat $665.037M Estimate
Chemed (NYSE:CHE) reported quarterly earnings of $6.06 per share which beat the analyst consensus estimate of $5.60 by 8.21 percent. This is a 41.92 percent increase over earnings of $4.27 per share from the same period
Benzinga Newsdesk
PRO
Chemed Raises FY2026 Adj EPS Guidance from $24.00-$24.75 to $25.00-$25.75 vs $24.34 Est
Chemed (NYSE:CHE) raises FY2026 Adj EPS guidance from $24.00-$24.75 to $25.00-$25.75 vs $24.34 analyst estimate..
Benzinga Newsdesk
PRO
Chemed Raises FY2026 Adj EPS Guidance from $23.25-$24.25 to $24.00-$24.75 vs $23.88 Est
Chemed (NYSE:CHE) raises FY2026 Adj EPS guidance from $23.25-$24.25 to $24.00-$24.75 vs $23.88 analyst estimate..
Benzinga Newsdesk
PRO
Chemed Q1 Adj. EPS $5.65 Beats $5.30 Estimate, Sales $657.513M Beat $649.819M Estimate
Chemed (NYSE:CHE) reported quarterly earnings of $5.65 per share which beat the analyst consensus estimate of $5.30 by 6.6 percent. This is a 0.36 percent increase over earnings of $5.63 per share from the same period
Benzinga Newsdesk
